Erba Diagnostics, Inc. Receivables Turnover Ratio (ERB), from the second quarter 2015 to the second quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Erba Diagnostics, Inc.  (ERB)
 

Erba Diagnostics Accounts Receivables Turnover Ratio from the second quarter 2015 to the second quarter 2013

Quarterly Results, Trends, Rankings, Statistics


Erba Diagnostics, Inc.'s ability to collect accounts receivable sequentially worsen to 3.6, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Erba Diagnostics's Accounts Receivable average collection period in the Jun 30 2015 quarter, has increased to 101 days, from 98 days, in the Mar 31 2014 quarter.

If we take a look into Healthcare sector 346 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2015 from to 3526.

What is Receivable Turnover Ratio?
What is Erba Diagnostics, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ERB Receivables Turnover Ratio (Jun 30 2015)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter
Y / Y Receivable Change 1.01 % 26.05 % 15.89 % 20.06 % 17.19 %
Y / Y Revenue Change -13.7 % -5.02 % 10.69 % 83.19 % 59.66 %
Receivable Turnover Ratio (TTM) 3.6 3.74 4.02 4.06 3.76
ERB's Total Ranking # 3526 # # # #
Accounts Receivable average collection period days 101 98 91 90 97
Seq. Receivable Change -19.47 % 15.59 % 3.28 % 5.07 % 0.5 %
Seq. Revenue Change -6.68 % -17.44 % 11.19 % 0.75 % 2.7 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 17
Healthcare Sector # 347
Overall Market # 3526

Receivable Turnover Ratio Statistics
High Average Low
4.42 3.82 2.97
(Jun 30 2013)   (Jun 30 2012)





ERB Company Profile • Back to ERB Efficiency Comparisons • Compare ERB Receivables Turnover Ratio to its Competitors

Financial Statements
Erba Diagnostics's Accounts Receivable $ 7 Millions Visit ERB's Balance sheet
Erba Diagnostics's Sales TTM $ 27 Millions Visit ERB's Income Statement
Sources of ERB's Revenues Visit ERB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ERB's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ERB's Growth Rates ERB's Roa ERB's Inventory Turnover Ratio ERB's Dividend Comparisons
ERB's Profitability Ratios ERB's Roi ERB's Asset Turnover Ratio ERB's Dividend Growth
ERB's Valuation Ratios ERB's Roe ERB's Financial Strength Ratios ERB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2015 Receivable at quarter ending Jun 30 2015
Encision Inc   10.68 $ 9.818  Millions$ 0.920  Millions
Lifemd Inc   10.66 $ 0.891  Millions$ 0.084  Millions
Cti Biopharma Corp   10.63 $ 61.151  Millions$ 5.754  Millions
Cba Florida Inc   10.57 $ 4.071  Millions$ 0.385  Millions
Vystar Corporation  10.11 $ 0.487  Millions$ 0.048  Millions
Corcept Therapeutics Inc  10.01 $ 38.353  Millions$ 3.833  Millions
Amphastar Pharmaceuticals Inc   9.95 $ 226.327  Millions$ 22.735  Millions
Allied Healthcare Products inc   9.95 $ 35.462  Millions$ 3.566  Millions
Dyne Therapeutics Inc   9.86 $ 3,075.000  Millions$ 311.750  Millions
Dyax Corp  9.75 $ 94.812  Millions$ 9.725  Millions
Biocryst Pharmaceuticals Inc   9.74 $ 41.352  Millions$ 4.244  Millions
Biodelivery Sciences International Inc   9.70 $ 19.156  Millions$ 1.976  Millions
Panbela Therapeutics Inc   9.45 $ 1.383  Millions$ 0.146  Millions
Ontrak Inc   9.44 $ 2.405  Millions$ 0.255  Millions
Dynatronics Corporation  9.42 $ 29.118  Millions$ 3.090  Millions
Regulus Therapeutics Inc   9.28 $ 13.336  Millions$ 1.437  Millions
Akebia Therapeutics Inc   9.25 $ 0.525  Millions$ 0.057  Millions
Igc Pharma Inc   9.24 $ 8.775  Millions$ 0.950  Millions
Antares Pharma Inc   9.18 $ 37.741  Millions$ 4.110  Millions
Spero Therapeutics Inc   9.13 $ 12.871  Millions$ 1.409  Millions
Henry Schein Inc   9.12 $ 10,418.791  Millions$ 1,142.585  Millions
Biocorrx Inc   9.09 $ 1.535  Millions$ 0.169  Millions
Scientific Industries Inc   9.06 $ 7.848  Millions$ 0.866  Millions
Adaptive Biotechnologies Corporation  9.01 $ 365.248  Millions$ 40.549  Millions
Luminex Corporation  8.92 $ 231.448  Millions$ 25.941  Millions
Davita Inc   8.91 $ 17,732.689  Millions$ 1,991.102  Millions
Cryoport inc   8.85 $ 4.786  Millions$ 0.541  Millions
Dynavax Technologies Corporation  8.83 $ 6.663  Millions$ 0.755  Millions
Tearlab Corp  8.82 $ 22.261  Millions$ 2.524  Millions
Cutera Inc   8.76 $ 85.859  Millions$ 9.798  Millions

Date modified: 2026-08-29T17:31:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.